Rituxan and Versed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rituxan (rituximab) and Versed (midazolam hydrochloride). Common drug interactions include haemoglobin decreased among females and abnormal behaviour among males.

The phase IV clinical study analyzes what interactions people have when they take Rituxan and Versed. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.

What is Versed?

Versed has active ingredients of midazolam hydrochloride. It is often used in sedation during medical procedure. eHealthMe is studying from 6,869 Versed users. Check the latest studies of Versed.



On Jul, 26, 2026

15 people who take Rituxan and Versed together, and have interactions are studied.

Rituxan and Versed drug interactions.

What are the common drug interactions of Rituxan and Versed, by gender? *:

female:

  1. Haemoglobin decreased
  2. Sensory disturbance (sense disturbance)
  3. Sinusitis (inflammation of sinus)
  4. Back pain
  5. Influenza like illness
  6. Muscle spasms (muscle contraction)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Pruritus (severe itching of the skin)
  9. Urinary tract infection
  10. Drug ineffective

male:

  1. Abnormal behaviour
  2. Abscess jaw (tooth abscess or root abscess)
  3. Blood pressure decreased
  4. Blood urea decreased
  5. Bone disorder
  6. Bone fragmentation
  7. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  8. Bone swelling
  9. Cachexia (loss of weight)
  10. Carbohydrate antigen 15-3 increased

What are the common drug interactions of Rituxan and Versed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Antibody test positive
  2. Proteinuria (presence of protein in the urine)
  3. Renal failure acute (rapid kidney dysfunction)

30-39:

n/a

40-49:

  1. Oedema (fluid collection in tissue)
  2. Renal failure (kidney dysfunction)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Chronic kidney disease
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Nephrogenic anaemia (anaemia due to kidney disease)

50-59:

n/a

60+:

  1. Asthenia (weakness)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Muscle spasms (muscle contraction)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Pruritus (severe itching of the skin)
  6. Urinary tract infection
  7. Drug ineffective
  8. Pleural effusion (water on the lungs)
  9. Abscess jaw (tooth abscess or root abscess)
  10. Actinomycosis (infection that causes sores, or abscesses)

What are the existing conditions these people have? *

  1. Pain: 4 people, 26.67%
  2. Breast Cancer Metastatic: 4 people, 26.67%
  3. Constipation: 3 people, 20.00%
  4. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 20.00%
  5. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 13.33%
  6. Transplant Rejection (a transplant material is not worked): 2 people, 13.33%
  7. Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 13.33%
  8. Dyspnea (difficult or laboured breathing): 2 people, 13.33%
  9. High Blood Pressure: 1 person, 6.67%
  10. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and Versed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rituxan and Versed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Versed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rituxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Versed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rituximab and midazolam hydrochloride (the active ingredients of Rituxan and Versed, respectively), and Rituxan and Versed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: